Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1672 1684 1686 3791
This examiner grants 14% of resolved cases
Robert Austin Player is an examiner in Tech Center 3700 and Art Unit 1672. The examiner has 21 resolved cases and an allowance rate of 14.3 percent. This low rate indicates a rigorous examination process where grants are less common. The median days to allowance is 1512, suggesting a prolonged timeline for those who do successfully navigate the prosecution process. With only 21 resolved cases, the data reflects a specific and perhaps more difficult path for applicants.
However, the interview lift is 33.8 percent, which is a significant increase over the 14.3 percent baseline allowance rate. This suggests that direct communication with the examiner is a critical factor in overcoming rejections and achieving an allowance. Practitioners should view the 33.8 percent lift as a vital strategic tool, especially given the low 14.3 percent general success rate. While the 1512 median days to allowance indicates a slow process, the high interview lift provides a clear method for improving outcomes in Art Unit 1672. The 21 resolved cases provide the basis for these metrics.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18066585 | INFORMATION PROCESSING APPARATUS, OPERATION METHOD FOR INFORMATION PROCESSING APPARATUS, AND OPERATION PROGRAM FOR INFORMATION PROCESSING APPARATUS | Non-Final OA | FUJIFILM Corporation |
| 17608441 | Reagents and Methods for Alzheimer's Disease and CoMorbidities Thereof | Final Rejection | Ohio State Innovation Foundation |
| 18184600 | Systems and Methods for Generating Ligand Compounds | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17398996 | APPLICATION OF DEEP LEARNING FOR INFERRING PROBABILITY DISTRIBUTION WITH LIMITED OBSERVATIONS | Final Rejection | International Business Machines Corporation |
| 18185760 | PHASELESS AUXILIARY-FIELD QUANTUM MONTE CARLO WITH DIRECT PRODUCT MULTI-SLATER DETERMINANTS TRIAL | Non-Final OA | Beijing Youzhuju Network Technology Co., Ltd. |
| 17691958 | MODULAR SYNTHON-BASED SCREENING APPROACH FOR USE IN DRUG DISCOVERY FOR DISEASES | Final Rejection | UNIVERSITY OF SOUTHERN CALIFORNIA |
| 17074343 | SYSTEMS AND METHODS FOR UNTARGETED METABOLOMIC SCREENING | Final Rejection | Northwestern University |
| 17609622 | ANALYTICAL DEVICE AND ANALYTICAL METHOD | Non-Final OA | SHIMADZU CORPORATION |
| 18258489 | METHOD OF SELECTING A GILT FOR BREEDING | Non-Final OA | Purdue Research Foundation |
| 17616421 | INFORMATION PROCESSING SYSTEM, INFORMATION PROCESSING METHOD, PROGRAM, AND METHOD FOR PRODUCING ANTIGEN-BINDING MOLECULE OR PROTEIN | Final Rejection | CHUGAI SEIYAKU KABUSHIKI KAISHA |
| 18008410 | METHODS AND SYSTEMS FOR DISTINGUISHING SOMATIC GENOMIC SEQUENCES FROM GERMLINE GENOMIC SEQUENCES | Final Rejection | Foundation Medicine, Inc. |
| 18968694 | Methods, Systems, and Devices for Hematologic Morphology Detection and Treatment | Non-Final OA | IDEXX Laboratories, Inc. |
| 17821410 | AUTOMATICALLY IDENTIFYING FAILURE SOURCES IN NUCLEOTIDE SEQUENCING FROM BASE-CALL-ERROR PATTERNS | Final Rejection | Illumina, Inc. |
| 17830316 | SELF-LEARNED BASE CALLER, TRAINED USING ORGANISM SEQUENCES | Non-Final OA | ILLUMINA, INC. |
| 17638904 | SYSTEMS AND METHODS FOR PREDICTING AND MONITORING TREATMENT RESPONSE FROM CELL-FREE NUCLEIC ACIDS | Final Rejection | Grail, LLC |
| 17050372 | SYSTEMS AND METHODS FOR USING PATHOGEN NUCLEIC ACID LOAD TO DETERMINE WHETHER A SUBJECT HAS A CANCER CONDITION | Final Rejection | GRAIL, LLC |
| 18168056 | DETERMINING VIABILITY AND TREATMENT OF DISEASE AGENTS | Non-Final OA | Institute for Systems Biology |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy